EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the Impact of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Mycophenolic Acid Through In Vitro and In Vivo Experiments

Chaoji Li iD, Min Zhang, Yanni Zhao, Dan Yang, Mei Zhao, Leyuan Shang, Xiaodong Sun, Shuo Zhang, Pengjiao Wang, Xiuli Gao

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms26010072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Chaoji Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025…. Hauptthemen laut MEDLINE: Mycophenolic Acid, Polyethylene Glycols, Excipients. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycophenolic acid (MPA) is a commonly used immunosuppressant. In the human body, MPA is metabolized into mycophenolic acid 7-O-glucuronide (MPAG) and mycophenolic acid acyl-glucuronide (AcMPAG) mainly through liver glucuronidation, which involves UDP-glucuronosyltransferase (UGTs) and transfer proteins. Research has indicated that the pharmaceutical excipient PEG400 can impact drug processes in the body, potentially affecting the pharmacokinetics of MPA. Due to the narrow therapeutic window of MPA, combination therapy is often used, and PEG400 is widely used in pharmaceutical preparations. Therefore, investigating the pharmacokinetic influence of PEG400 on MPA could offer valuable insights for optimizing MPA’s clinical use. In this study, we examined the impact of a single oral dose of PEG400 on the blood levels of MPA in rats through pharmacokinetic analysis. We also investigated the distribution of MPA in various tissues using mass spectrometry imaging. We explored the potential mechanism by which PEG400 affects the metabolism of MPA using hepatic and intestinal microsomes and the Caco-2 cellular transporter model. Our findings reveal that the overall plasma concentrations of MPA were elevated in rats following the co-administration of PEG400, with the AUC0-t of MPA and its metabolite MPAG increasing by 45.53% and 29.44%, respectively. Mass spectrometry imaging showed increased MPA content in tissues after PEG400 administration, with significant differences in the metabolites observed across different tissues. Microsomal and transport experiments showed that PEG400 accelerated the metabolism of MPA, promoted the uptake of MPA, and inhibited efflux. In conclusion, PEG400 alters the in vivo metabolism of MPA, potentially through the modulation of metabolic enzymes and transport.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycophenolic AcidPolyethylene GlycolsExcipientsAnimalsHumansRatsCaco-2 CellsMaleMicrosomes, LiverRats, Sprague-DawleyTissue DistributionGlucuronosyltransferaseAdministration, OralGlucuronides

Stichwörter der Autor:innen

metabolizing enzymemycophenolic acidpharmaceutical excipient–drug interactionspharmacokineticspolyethylene glycol 400transport

Substanzen

Mycophenolic AcidPolyethylene Glycolspolyethylene glycol 400ExcipientsGlucuronosyltransferaseGlucuronides

Autor:innen und Institutionen

  • State Key Laboratory of Functions and Applications of Medicinal Plants, School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang 550025, China.
  • Center of Microbiology and Biochemical Pharmaceutical Engineering, Department of Education of Guizhou, Guiyang 550025, China.
  • School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, China.
  • Experimental Animal Center, Guizhou Medical University, Guiyang 550025, China.

ORCID-Profile: Chaoji Li

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, C., Zhang, M., Zhao, Y., Yang, D., Zhao, M., Shang, L., Sun, X., Zhang, S., Wang, P., & Gao, X. (2024). Exploring the Impact of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Mycophenolic Acid Through In Vitro and In Vivo Experiments. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26010072

Vancouver

Li C, Zhang M, Zhao Y, Yang D, Zhao M, Shang L, et al. Exploring the Impact of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Mycophenolic Acid Through In Vitro and In Vivo Experiments. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms26010072

BibTeX
@article{Li2024,
  author = {Li, Chaoji and Zhang, Min and Zhao, Yanni and Yang, Dan and Zhao, Mei and Shang, Leyuan and Sun, Xiaodong and Zhang, Shuo and Wang, Pengjiao and Gao, Xiuli},
  title = {Exploring the Impact of Pharmaceutical Excipient PEG400 on the Pharmacokinetics of Mycophenolic Acid Through In Vitro and In Vivo Experiments},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms26010072}
}
Kostenlos starten →